LaurenceBusseMD, MBA, FCCM

Internal Medicine • Johns Creek, GA

Critical Care Medicine

Associate Professor, Emory University School of Medicine; Medical Director, Critical Care, Emory Johns Creek Hospital

Join to view full profile

Dr. Busse is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Busse's full profile

Already have an account?

Office
6325 Hospital Pkwy
Johns Creek, GA 30097

Summary

Dr. Laurence Busse is an intensivist in Johns Creek, GA and is the Medical Director of Critical Care at Emory Johns Creek Hospital. He also serves as the site director for critical care of the Emory Critical Care Center. He is currently an Associate Professor in the Emory University SOM. He received his medical degree from George Washington University School of Medicine. He specializes in critical care medicine and is experienced in acute renal failure, sepsis, endotracheal intubation, shock, and hemodynamics.

Education & Training

George Washington University School of MedicineFellowship, Critical Care Medicine, 2011 - 2013
George Washington UniversityResidency, Internal Medicine, 2008 - 2011
George Washington University School of Medicine and Health SciencesClass of 2008

Certifications & Licensure

GA State Medical License 2016 - 2026
VA State Medical License 2010 - 2020
MD State Medical License 2016 - 2018
DC State Medical License 2008 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine

Clinical Trials

Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Completed
Phase 2, Phase 3
Study of Suramin in Subjects With Furosemide-Resistant AKI Start of enrollment: 2020 Nov 13
Active, not recruiting
Phase 2
(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI Start of enrollment: 2020 Nov 02
Terminated
Phase 3
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 Start of enrollment: 2020 Nov 18
Completed
Phase 4
Vitamin C, Thiamine, and Steroids in Sepsis Start of enrollment: 2018 Aug 22
Completed
Phase 3
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension Start of enrollment: 2015 Mar 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, Caitlin C Ten Lohuis, Nathan D Nielsen
Journal of Critical Care. 2024-11-14
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the Uni...
Jennifer DeCuir, Diya Surie, Yuwei Zhu, Adam S Lauring, Manjusha Gaglani
Influenza and Other Respiratory Viruses. 2024-11-01
1 citations
Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial.
Mark C Chappell, Christopher L Schaich, Laurence W Busse, Greg S Martin, Jonathan E Sevransky
Critical Care. 2024-10-14

Journal Articles

Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients with Sepsis
Jonathan E Sevransky, Richard E Rothman, David N Hager, Laurence W Busse, David F Gaieski, Michelle N Gong, Jeremiah S Hinson, Michael H Hooper, Gabor D Kelen, Katheri..., JAMA

Press Mentions

ACEI/ARBs Linked with Survival in Hypertensive, Chinese COVID-19 PatientsApril 22nd, 2020